SPONSOR
Shanghai Henlius Biotech
Total Trials
5
Recruiting
5
Phases
Phase 1, Phase 2, Phase 1, Phase 2, EARLY_Phase 1
Conditions studied: Solid Tumor CancerNon Small Cell Lung CancerMultiple Myeloma (MM)Carcinoma, HepatocellularAdvanced/Metastatic Solid TumorsNSCLCSCLCNEC
Shanghai Henlius Biotech is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Solid Tumor Cancer, Non Small Cell Lung Cancer, Multiple Myeloma (MM), Carcinoma, Hepatocellular.
The trial portfolio spans Phase 1, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Henlius Biotech
How many clinical trials has Shanghai Henlius Biotech sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Shanghai Henlius Biotech, of which 5 are actively recruiting participants. These trials cover conditions including Solid Tumor Cancer, Non Small Cell Lung Cancer, Multiple Myeloma (MM). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Henlius Biotech research focus on?
Shanghai Henlius Biotech clinical trials span Solid Tumor Cancer, Non Small Cell Lung Cancer, Multiple Myeloma (MM), Carcinoma, Hepatocellular, Advanced/Metastatic Solid Tumors, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Henlius Biotech clinical trial?
To participate in a Shanghai Henlius Biotech trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Henlius Biotech trials with current recruitment status updated daily.
Clinical Trials by Shanghai Henlius Biotech
NCT06848699 Phase 1, Phase 2
Recruiting
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
Solid Tumor Cancer
NCT07477587 Phase 1
Recruiting
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM)
NCT06349980 Phase 2
Recruiting
A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.
Carcinoma, Hepatocellular
NCT07274813 EARLY_Phase 1
Recruiting
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors
Advanced/Metastatic Solid Tumors
NCT07416695 Phase 1
Recruiting
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC
SCLC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology